Φορτώνει......
Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
BACKGROUND & AIMS: There are few data from prospective studies on the effects of aspirin on fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: We performed a prospective cohort study of 361 adults with biopsy-confirmed NAFLD, from 2006 through 2015, examined every 3–12...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Gastroenterol Hepatol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842070/ https://ncbi.nlm.nih.gov/pubmed/31077838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2019.04.061 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|